Given Imaging Reports New Studies on PillCam(R) COLON 2 Presented at UEG Week
October 22, 2012 10:42 am | by The Associated Press | News | CommentsGiven Imaging Ltd. (NASDAQ: GIVN), a world leader in GI medical devices and pioneer of capsule endoscopy, today announced three new studies confirming the value of PillCam® COLON 2 in a range of clinical settings, including as an evaluation tool for triaging FIT-positive patients for...
Four Terminal Current Sense Resistors
October 22, 2012 10:40 am | Product Releases | CommentsOhmite Manufacturing Company, a leading provider of thermal solutions and resistors for high current, high voltage and high energy applications, announces that it has expanded its FC4L Series of four terminal current sense resistors.
Portable, Fast, and Accurate Counting Scale
October 22, 2012 10:21 am | Alliance Scale, Inc. | Product Releases | CommentsAn accurate and rugged, battery operated portable electronic counting scale that has a stainless steel pan, sealed keypad, and stores 10 average part weights is available from Alliance Scale, Inc.
Vascular Solutions Launches R-Band Radial Hemostasis Device
October 22, 2012 9:48 am | by Globe Newswire | News | CommentsVascular Solutions, Inc. today announced that it has launched the R-Band radial hemostasis compression device in the United States. Vascular Solutions is the exclusive distributor of the R-Band device in the U.S. under an agreement entered into with Lepu Medical Technology (Beijing) Co., Ltd., the developer and manufacturer of the device.
Implantable devices are not a luxury
October 22, 2012 9:42 am | by European Society of Cardiology | News | Comments“Implantable devices can save lives and decrease mortality, they are not a luxury” said Professor Angelo Auricchio, President of the European Heart Rhythm Association (EHRA) of the ESC at the ICD for Life Summit which concluded in Belgrade, Serbia, today. “In the face of the impressive rise in cardiovascular related mortality in Central and Eastern Europe, we need to implement a structured approach...
LifeTech Scientific Corp, DiNova Venture Partners & Broncus Technologies, Inc. Form Lung Cancer Partnership
October 22, 2012 9:37 am | by The Associated Press | News | CommentsLifeTech Scientific Corp. (8122:HK; Hong Kong Stock Exchange), DiNova Venture Partners, LLC (Shanghai, China), Themes Investment Partners (Hong Kong, China) and Broncus Technologies, Inc., announced the formation of Broncus Medical, Inc., a global strategic partnership to develop and...
Micro Interventional Devices, Inc. Initiates "First-in-Man" Clinical Study of PermasealT
October 22, 2012 8:07 am | by The Associated Press | News | CommentsMicro Interventional Devices, Inc.T (MID), an emerging cardiovascular medical device company, announced today that the first patient has been treated using its self-sealing, cardiac access and closure technology, PermasealT. The patient is the first to be enrolled in the company's STASIS ...
Given Imaging Announces New Studies Highlighting Diverse Applications of ManoScan(TM) High Resolution Manometry
October 22, 2012 8:03 am | by The Associated Press | News | CommentsGiven Imaging Ltd (NASDAQ: GIVN), a world leader in GI medical devices and pioneer of capsule endoscopy, today announced data from numerous studies highlighting the value of ManoScan high resolution manometry in assessing esophageal and anorectal muscle function. The studies are being...
Varian Medical Systems Expands Market Leadership Position at 2012 ASTRO Meeting in Boston
October 22, 2012 8:02 am | by The Associated Press | News | CommentsASTRO Booth #5019 -- Varian Medical Systems (NYSE: VAR) will showcase new technologies that highlight its expanding leadership position in the radiation oncology market at the 54th annual meeting of the American Society for Radiation Oncology (ASTRO) in Boston starting on Sunday. The company ...
FDA Approves GORE® Septal Occluder for Use in Gore REDUCE Clinical Study
October 22, 2012 8:00 am | by The Associated Press | News | CommentsFLAGSTAFF, Ariz. & MIAMI--(BUSINESS WIRE)--Oct 22, 2012--W. L. Gore & Associates (Gore) today announced that the FDA has approved the use of the new GORE® Septal Occluder for inclusion in the Gore REDUCE Clinical Study. Gore is introducing this latest technology in its Gore REDUCE Clinical...
ECA Medical Instruments Launches New Single-Procedure Torque-Limiting Instruments and Kits for Orthopaedic Surgeons
October 22, 2012 8:00 am | by The Associated Press | News | CommentsNEWBURY PARK, Calif.--(BUSINESS WIRE)--Oct 22, 2012--ECA Medical Instruments, the leading designer and manufacturer of single-procedure torque-limiting surgical instruments and kits to the medical industry and surgeons worldwide, announced today the introduction of new instruments and kits for...
Cappella Medical Announces Excellent Long Term Follow-Up Results for Its Sideguard® Technology at TCT 2012
October 22, 2012 8:00 am | by The Associated Press | News | CommentsGALWAY, Ireland--(BUSINESS WIRE)--Oct 22, 2012--Cappella Medical Devices Ltd (Cappella), a medical device company developing dynamic solutions for the treatment of coronary bifurcation disease, today announced the multicenter long term follow up results for its innovative Sideguard ® coronary...
Derma Sciences on Track to Begin Phase 3 Program with DSC127 in December Following Meeting with FDA
October 22, 2012 7:30 am | by The Associated Press | News | CommentsPRINCETON, N.J.--(BUSINESS WIRE)--Oct 22, 2012--Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today reported that based on a meeting held last week with the U.S. Food and Drug Administration (FDA), the Company plans to begin its...
BIO-Europe® 2012 Presenting Companies Offer Preview of Market Innovation to VC and Pharma Investors
October 22, 2012 6:00 am | by The Associated Press | News | CommentsZURICH & HAMBURG, Germany--(BUSINESS WIRE)--Oct 22, 2012--The 18th annual BIO-Europe® international partnering conference will be held in Hamburg, Germany November 12–14, 2012 at the CCH Congress Center Hamburg. Europe’s largest partnering conference attracts the world’s top dealmakers from...
Stock analyst: BSX struggles will continue for a while
October 22, 2012 12:00 am | by Mass High Tech: The Journal of New England Technology | News | CommentsAs Boston Scientific Corp. (NYSE: BSX) plans a number of announcements in coming days at one of the largest annual cardiovascular conferences in the U.S., it’s coming off a quarterly report that shows a year-to-date net loss of more than $4 billion, and at least one stock analyst says he doubts this week’s presentations will do much to change that.


